FDA Orange Book

Is there a generic for Horizant?

Horizant contains gabapentin enacarbil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Horizant (gabapentin enacarbil). The Orange Book shows its last listed patent expires June 10, 2029.

Run it in Rivvi

Map Horizant and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Horizant products in the Orange Book

Horizant products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, extended release, oral300MGMarketed (Rx)None0None
tablet, extended release, oral600MGMarketed (Rx)None0None

NDA 022399, held by AZURITY PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Horizant patents

Patents listed for Horizant
PatentExpiresCoversUse codeNDA
8114909April 11, 2026Method of useU-1231022399
8026279November 10, 2026Drug substance, Drug productNone022399
8795725June 10, 2029Drug productU-1231022399
8795725June 10, 2029Drug productU-1247022399

Horizant NDC codes

Questions

Is there a generic for Horizant?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Horizant (gabapentin enacarbil). The Orange Book shows its last listed patent expires June 10, 2029.

What is the generic name for Horizant?

The active ingredient in Horizant is gabapentin enacarbil, per the FDA Orange Book.

When does the Horizant patent expire?

The last patent listed for Horizant in the Orange Book expires June 10, 2029. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Horizant and Gabapentin Enacarbil

Try it on your own data today.

Free to start. Most teams are using it the same day.